DBS TaT in Peer-assisted Telemedicine for Hepatitis C

NARecruitingINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

January 22, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

May 31, 2026

Conditions
Hepatitis C
Interventions
OTHER

DBS TaT

Dried Blood Spot (DBS) testing for HCV DCHEQ and Baseline Surveys If at high risk for liver fibrosis, blood draw prior to treatment initiation If low risk for liver fibrosis, Telemedicine visit with PATHS provider HCV treatment initiation Transient elastography (TEG)

OTHER

Usual Care

Point-of-care or DBS testing for HCV Blood draw to test liver fibrosis DCHEQ and Baseline Surveys Telemedicine visit with PATHS provider HCV treatment initiation Transient elastography (TEG)

Trial Locations (1)

97239

RECRUITING

Oregon Health & Science University, Portland

All Listed Sponsors
collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

collaborator

Oregon Clinical and Translational Research Institute

OTHER

collaborator

Collins Medical Trust

OTHER

lead

Oregon Health and Science University

OTHER